We are live on ! Find out more
ELEV

Elevation Oncology
ELEV

Delisted

ELEV was delisted on the 22nd of July, 2025.

Back to rankings

22 hedge funds and large institutions have $123M invested in Elevation Oncology in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 4

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

2.58% less ownership

Funds ownership: 70.96% → 68.37% (-2.6%)

39% less funds holding

Funds holding: 36 → 22 (-14)

43% less capital invested

Capital invested by funds: $217M → $123M (-$94M)

70% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 20

Holders
22
Holders Change
-14
Holders Change %
-38.89%
% of All Funds
0.39%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
6
Increased
5
Reduced
4
Closed
20
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$6.44M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$2.04M
3
BlackRock
BlackRock
New York
+$258K
4
State Street
State Street
Massachusetts
+$200K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$131K

Top Sellers

Rank Fund Capital Flow
1
MIM
Monashee Investment Management
Massachusetts
-$1.9M
2
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$1.7M
3
PAMP
Polar Asset Management Partners
Ontario, Canada
-$1.7M
4
Millennium Management
Millennium Management
New York
-$1.67M
5
GTC
Ghost Tree Capital
New York
-$1.36M
Name Holding Trade Value Shares
Change 		Change in
Stake
GTC
26
Ghost Tree Capital
New York
– -$1.36M -100,000 Closed
HM
27
HealthCor Management
New York
– -$1.36M -100,000 Closed
Hudson Bay Capital Management
28
Hudson Bay Capital Management
Connecticut
– -$1.09M -80,000 Closed
Goldman Sachs
29
Goldman Sachs
New York
– -$848K -62,500 Closed
Point72 Asset Management
30
Point72 Asset Management
Connecticut
– -$679K -50,000 Closed
PCM
31
Pinz Capital Management
New York
– -$494K -36,400 Closed
LP
32
LMR Partners
United Kingdom
– -$425K -31,300 Closed
SFM
33
Sphera Funds Management
Israel
– -$407K -30,000 Closed
Qube Research & Technologies (QRT)
34
Qube Research & Technologies (QRT)
United Kingdom
– -$329K -24,255 Closed
MS
35
Maven Securities
Jersey
– -$204K -16,000 Closed
PHK
36
Point72 Hong Kong
Hong Kong
– -$131K -9,649 Closed
Northern Trust
37
Northern Trust
Illinois
– -$65K -4,803 Closed
UBS Group
38
UBS Group
Switzerland
– -$14K -1,045 Closed
WCMNY
39
Westchester Capital Management (New York)
New York
– -$14K -1,000 Closed
OCM
40
Ovata Capital Management
Hong Kong
– -$7K -500 Closed
CSS
41
Cubist Systematic Strategies
Connecticut
– -$1K -100 Closed
Wells Fargo
42
Wells Fargo
California
– +$411 +38 New
1
2

ELEV Hedge Fund Activity: Q3 2021 in Review

22 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Elevation Oncology (ELEV) for Q3 2021, worth a combined $123M — down 43% from $217M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of ELEV and 6 opened new positions — a net loss of 14 holders — while 4 trimmed existing stakes and 5 added.

The largest buyer was Vanguard Group, adding an estimated $6.44M. The largest seller was Monashee Investment Management, exiting entirely with an estimated $1.9M sold.

  • 22 institutional investors held Elevation Oncology (ELEV) as of Q3 2021, down from 36 in Q2 2021.
  • Funds reported $123M of Elevation Oncology stock for Q3 2021, down 43% quarter-over-quarter.
  • 6 funds opened new Elevation Oncology positions in Q3 2021 and 20 closed out, a net change of -14 holders.
  • The largest Elevation Oncology buyer in Q3 2021 was Vanguard Group, an estimated $6.44M added.
  • The largest Elevation Oncology seller in Q3 2021 was Monashee Investment Management, an estimated $1.9M sold.

Based on aggregated 13F filings for Q3 2021.